e-Drug3D 1449 |
PLERIXAFOR
|
cas 110078-46-1 |
CLASS IMMUNOMODULATING |
ROUTE (list) SUBCUTANEOUS |
ATC code |
PK parameters VD 19.5 LITER (65 KILOGRAM) |
Target TARGET ALPHA-CHEMOKINE RECEPTOR CXCR4 PDB Ligand code = VH6 (link to the list of PDB complexes) Download experimental 3D coordinates of VH6 with added hydrogens |
DrugCentral C-X-C chemokine receptor type 4 UNIPROT P61073 CXCR4 |
Download SDF file | 1,4,8,11-Tetraazacyclotetradecane, 1,1'-[1,4-phenylenebis(methylene)]bis- Formula: Calculated chemical properties: MW 502.79 NB_atoms 36 XLogP 0.42 PSA 89.265 NB_HD 6 NB_HA 8 fsp3 0.79 Lipinski(0=no;1=yes) 0 |
FDA NDA 022311 (label) INN (PLERIXAFOR) MOZOBIL (GENZYME) APPROVAL= AP YEAR= 2008 NDA 205182 (pdf not found) INN (PLERIXAFOR) PLERIXAFOR (DR REDDYS) APPROVAL= AP YEAR= 2023 NDA 211901 (pdf not found) INN (PLERIXAFOR) PLERIXAFOR (MSN) APPROVAL= AP YEAR= 2023 NDA 213672 (pdf not found) INN (PLERIXAFOR) PLERIXAFOR (EUGIA PHARMA) APPROVAL= AP YEAR= 2023 NDA 215698 (pdf not found) INN (PLERIXAFOR) PLERIXAFOR (MEITHEAL) APPROVAL= AP YEAR= 2023 NDA 208980 (pdf not found) INN (PLERIXAFOR) PLERIXAFOR (ZYDUS PHARMS) APPROVAL= AP YEAR= 2023 DISCONTINUED NDA 205197 (pdf not found) INN (PLERIXAFOR) PLERIXAFOR (TEVA PHARMS USA INC) APPROVAL= AP YEAR= 2023 NDA 215334 (pdf not found) INN (PLERIXAFOR) PLERIXAFOR (AMNEAL) APPROVAL= AP YEAR= 2023 NDA 206644 (pdf not found) INN (PLERIXAFOR) PLERIXAFOR (GLAND) APPROVAL= AP YEAR= 2024 NDA 217560 (pdf not found) INN (PLERIXAFOR) PLERIXAFOR (HETERO LABS LTD VI) APPROVAL= AP YEAR= 2025 |
Other links: |